Zhang Wen-Di, Shi Zhuang-E, Zhang Meng-Yu, Yin Yun-Hong, Li Hao, Qu Yi-Qing
Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of Infectious Respiratory Diseases, Jinan, China.
Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Shandong Key Laboratory of Infectious Respiratory Diseases, Jinan, China.
Ann Transl Med. 2023 Aug 30;11(10):365. doi: 10.21037/atm-22-4049. Epub 2023 Jun 14.
Pulmonary sclerosing pneumocytoma (PSP) is a rare benign lung tumor which generally presents as a solitary pulmonary nodule in middle-aged females. However, the PSP in some patients exhibits potentially malignant biological behavior, with recurrence and lymphatic or distant metastasis being observed.
We encountered a case of a 46-year-old female with an inordinately massive tumor 9.5 cm in diameter and a relatively high Ki-67 proliferation rate. Fine needle aspiration (FNA) played a significant but limited role in the preoperative diagnosis: the computed tomography (CT)-guided lung puncture biopsy was consistent with the typical pathology of PSP; however, endobronchial ultrasound-guided transbronchial lung biopsy (EBUS-TBLB) could not provide a definitive diagnosis. The patient ultimately underwent thoracoscopic resection and mediastinal lymph node dissection. Here, we provide a review of the literature on patients with PSP with malignant biological behavior to raise awareness of the malignant potential of PSP and describe our experience to inform future management.
PSP lacks specificity in its clinical and radiological characteristics and has complex pathological manifestations. FNA is valuable in the diagnosis and differential diagnosis of PSP but involves the risk of misdiagnosis or missed diagnosis. Additionally, we believe that the accepted benign features of PSP need to be updated and that the potential malignant features of PSP should be carefully monitored. Surgical resection is curative but strict follow-up is crucial.
肺硬化性肺细胞瘤(PSP)是一种罕见的良性肺肿瘤,通常表现为中年女性的孤立性肺结节。然而,部分患者的PSP表现出潜在的恶性生物学行为,可出现复发及淋巴或远处转移。
我们遇到一例46岁女性患者,其肿瘤直径达9.5 cm,体积异常巨大,且Ki-67增殖率相对较高。细针穿刺抽吸(FNA)在术前诊断中发挥了重要但有限的作用:计算机断层扫描(CT)引导下的肺穿刺活检结果与PSP的典型病理相符;然而,支气管内超声引导下经支气管肺活检(EBUS-TBLB)未能提供明确诊断。该患者最终接受了胸腔镜切除及纵隔淋巴结清扫术。在此,我们回顾了关于具有恶性生物学行为的PSP患者的文献,以提高对PSP恶性潜能的认识,并描述我们的经验,为未来的治疗提供参考。
PSP在临床和影像学特征上缺乏特异性,病理表现复杂。FNA在PSP的诊断和鉴别诊断中具有重要价值,但存在误诊或漏诊的风险。此外,我们认为PSP公认的良性特征需要更新,其潜在的恶性特征应予以密切监测。手术切除可治愈疾病,但严格的随访至关重要。